Topical Therapies for Refractory Chronic Rhinosinusitis.
Publication/Presentation Date
2-1-2017
Abstract
Topical therapy has become an important tool in the otolaryngologist's armamentarium for refractory chronic rhinosinusitis (CRS). Daily high-volume sinonasal saline irrigation and standard metered-dose topical nasal steroid therapy are supported by the most evidence. Nonstandard topical sinonasal steroid therapies are a potential option for refractory CRS. Current evidence recommends against the use of topical antifungal therapy and topical antibiotic therapy delivered using spray and nebulized techniques in routine cases of CRS. Stents are a new modality with preliminary data showing they are an option when traditional treatment has failed. Further research with long-term effects and outcomes studies for refractory CRS are needed.
Volume
50
Issue
1
First Page
129
Last Page
141
ISSN
1557-8259
Published In/Presented At
Sanan, A., Rabinowitz, M., Rosen, M., & Nyquist, G. (2017). Topical Therapies for Refractory Chronic Rhinosinusitis. Otolaryngologic clinics of North America, 50(1), 129–141. https://doi.org/10.1016/j.otc.2016.08.011
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
27888909
Department(s)
Administration and Leadership
Document Type
Article